GSA Capital Partners’s Seaport Therapeutics SPTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SPTX
GSA Capital Partners's SPTX Position: Q3 2026 in Review
GSA Capital Partners increased its Seaport Therapeutics (SPTX) stake by 9.4% in Q3 2026, buying an estimated $69.6K and bringing the position to 36,310 shares worth $732K. The position accounts for 0.04% of the portfolio, ranked #804.
GSA Capital Partners first reported a position in SPTX in Q2 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.
- GSA Capital Partners held 36,310 shares of Seaport Therapeutics worth $732K as of Q3 2026.
- GSA Capital Partners bought 3,132 Seaport Therapeutics shares in Q3 2026, an estimated $69.6K.
- Seaport Therapeutics made up 0.04% of GSA Capital Partners's portfolio in Q3 2026, its #804 holding.
- GSA Capital Partners first reported a position in Seaport Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 74 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.